Women’s Health Bulletin

Published by: Kowsar
Crossmark

The Effect of Resistance Training in Water and Land with Vitamin D Supplementation on Anti-Mullerian Hormone in Women with Polycystic Ovary Syndrome

Seyed Ali Hosseini 1 , Nasibeh Kazemi 1 , * , Saeedeh Shadmehri 2 , Shariat Jalili 1 and Mozhgan Ahmadi 2
Authors Information
1 Department of Sport Physiology, Marvdasht Branch, Islamic Azad University, Marvdasht, Iran
2 Department of Physical Education, Yadegar-e-Imam Khomeini (RAH) Shahre-Rey Branch, Islamic Azad University, Tehran, Iran
Article information
  • Women’s Health Bulletin: April 1, 2019, 6 (2); e84882
  • Published Online: April 8, 2019
  • Article Type: Research Article
  • Received: October 2, 2018
  • Revised: February 16, 2019
  • Accepted: February 20, 2019
  • DOI: 10.5812/whb.84882

To Cite: Hosseini S A, Kazemi N, Shadmehri S , Jalili S, Ahmadi M. The Effect of Resistance Training in Water and Land with Vitamin D Supplementation on Anti-Mullerian Hormone in Women with Polycystic Ovary Syndrome, Women Health Bull. 2019 ; 6(2):e84882. doi: 10.5812/whb.84882.

Abstract
Copyright © 2019, Women’s Health Bulletin. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Footnotes
References
  • 1. Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod. 2012;27(10):3067-73. doi: 10.1093/humrep/des232. [PubMed: 22777527].
  • 2. Dunaif A. Drug insight: Insulin-sensitizing drugs in the treatment of polycystic ovary syndrome--a reappraisal. Nat Clin Pract Endocrinol Metab. 2008;4(5):272-83. doi: 10.1038/ncpendmet0787. [PubMed: 18364705].
  • 3. Orio F, Vuolo L, Palomba S, Lombardi G, Colao A. Metabolic and cardiovascular consequences of polycystic ovary syndrome. Minerva Ginecol. 2008;60(1):39-51. [PubMed: 18277351].
  • 4. Jamilian M, Bakhshayeshy S. [To study the effect of calcium plus vitamin D supplementation on nitric oxide and biomarkers of oxidative stress in overweight and obess women with polycystic ovary syndrome]. Arak Med Univ J (AMUJ). 2016;19(6):27-36. Persian.
  • 5. Miller PB, Forstein DA, Styles S. Effect of short-term diet and exercise on hormone levels and menses in obese, infertile women. J Reprod Med. 2008;53(5):315-9. [PubMed: 18567275].
  • 6. Saremi A, Bahrami A, Jamilian M, Moazami Goodarzi P. [Effects of 8 weeks pilates training on anti-Mullerian hormone level and cardiometabolic parameters in polycystic ovary syndrome women]. Arak Med Univ J (AMUJ). 2014;17(9):59-69. Persian.
  • 7. Moran LJ, Harrison CL, Hutchison SK, Stepto NK, Strauss BJ, Teede HJ. Exercise decreases anti-Mullerian hormone in anovulatory overweight women with polycystic ovary syndrome: A pilot study. Horm Metab Res. 2011;43(13):977-9. doi: 10.1055/s-0031-1291208. [PubMed: 21989557].
  • 8. Woodward A. The effects of a structured 8-week aerobic exercise intervention on anti-Mullerian hormone levels and oxidised LDL-cholesterol in the polycystic ovarian syndrome. University of Hull; 2016.
  • 9. Leonhardt H, Hellstrom M, Gull B, Lind AK, Nilsson L, Janson PO, et al. Serum anti-Mullerian hormone and ovarian morphology assessed by magnetic resonance imaging in response to acupuncture and exercise in women with polycystic ovary syndrome: secondary analyses of a randomized controlled trial. Acta Obstet Gynecol Scand. 2015;94(3):279-87. doi: 10.1111/aogs.12571. [PubMed: 25545309].
  • 10. Zar A, Hosseini SA, Homaion A. [Effect of eight-week aquagymnastic training on liver enzymes and lipid profile of middle-aged women]. Qom Univ Med Sci J. 2016;10(7):29-37. Persian.
  • 11. Barzanjeh SP, Ghal'e Nouie F, Mirzaei S. [Effect of 12 months of strength training in water on bone mineral density of the lumbar spine and femoral neck in postmenopausal women with osteoporosis]. J Kurdistan Univ Med Sci. 2017;21(6):27-35. Persian.
  • 12. Pellatt L, Rice S, Mason HD. Anti-Mullerian hormone and polycystic ovary syndrome: A mountain too high? Reproduction. 2010;139(5):825-33. doi: 10.1530/REP-09-0415. [PubMed: 20207725].
  • 13. Eldar-Geva T, Margalioth EJ, Gal M, Ben-Chetrit A, Algur N, Zylber-Haran E, et al. Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism. Hum Reprod. 2005;20(7):1814-9. doi: 10.1093/humrep/deh873. [PubMed: 15802320].
  • 14. Moran LJ, Noakes M, Clifton PM, Norman RJ. The use of anti-Mullerian hormone in predicting menstrual response after weight loss in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2007;92(10):3796-802. doi: 10.1210/jc.2007-1188. [PubMed: 17652213].
  • 15. Ostad Rahimi A, Zarghami N, Sadighi A, Alani B, Dostzadeh A. [Prevalence of vitamin D deficiency and other possible risk factors in reproductive age women in Tabriz]. Med J Tabriz Univ Med Sci. 2006;25(4):7-11. Persian.
  • 16. Thys-Jacobs S, Donovan D, Papadopoulos A, Sarrel P, Bilezikian JP. Vitamin D and calcium dysregulation in the polycystic ovarian syndrome. Steroids. 1999;64(6):430-5. [PubMed: 10433180].
  • 17. Vigorito C, Giallauria F, Palomba S, Cascella T, Manguso F, Lucci R, et al. Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2007;92(4):1379-84. doi: 10.1210/jc.2006-2794. [PubMed: 17264174].
  • 18. Thomson RL, Buckley JD, Brinkworth GD. Exercise for the treatment and management of overweight women with polycystic ovary syndrome: A review of the literature. Obes Rev. 2011;12(5):e202-10. doi: 10.1111/j.1467-789X.2010.00758.x. [PubMed: 20546140].
  • 19. Randeva HS, Lewandowski KC, Drzewoski J, Brooke-Wavell K, O'Callaghan C, Czupryniak L, et al. Exercise decreases plasma total homocysteine in overweight young women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2002;87(10):4496-501. doi: 10.1210/jc.2001-012056. [PubMed: 12364425].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments